← Leaderboards
Chinglai Yang
Emory University
$3,676,986
Attributed
$3,676,986
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $731.8K · FY2006–17$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$3,676,986 · 4
By mechanism
R01$2,551,532 · 1
R21$1,125,454 · 3
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Rama Rao Amara$90,840,294
- Guido Silvestri$61,186,493
- Harold M. McClure$3,517,681
- Victor G. Corces$25,865,156
- Vijayakumar Velu$8,193,463
Others in their field
Top investigators on “Vaccine Development”
- Lawrence Corey · Fred Hutchinson Cancer Center$718,120,301
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$554,939,981
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$394,383,754
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$392,263,550
- Dennis R. Burton · Scripps Research Institute$312,611,400
Research focus
Vaccine DevelopmentAids VaccinesNeutralizing AntibodyChimeric ProteinsAntibodiesNovel VaccinesVaccinesProteinsSurfaceInfectionImmunizationResponseBaseAntigensAdjuvantAids Vaccine DevelopmentGlycoproteinsGlycosylationCell SurfaceEpitopesCell SeparationDesignCompare EffectivenessExhibits
Grant awards (9)
Targeting neutralizing epitopes in the MPER of HIV Env$731,756
R01 · FY2017 · AI · contact PI
Targeting neutralizing epitopes in the MPER of HIV Env$649,613
R01 · FY2016 · AI · contact PI
Targeting neutralizing epitopes in the MPER of HIV Env$654,069
R01 · FY2015 · AI · contact PI
Targeting neutralizing epitopes in the MPER of HIV Env$516,094
R01 · FY2014 · AI · contact PI
Novel DNA/VLP Vaccines Against Influenza$185,704
R21 · FY2007 · AI · contact PI
Novel DNA/VLP Vaccines Against Influenza$229,500
R21 · FY2006 · AI · contact PI
ENHANCEMENT OF CTL RESPONSE AGAINST SHIV ANTIGENS$240,000
R21 · FY2001 · AI
ENHANCEMENT OF CTL RESPONSE AGAINST SHIV ANTIGENS$240,000
R21 · FY2000 · AI
ENHANCING OF IMMUNOGENICITY OF SHIV VLPS BY CD4 BINDING$230,250
R21 · FY2000 · AI